loader image
Thursday, December 18, 2025
81.1 F
McAllen
- Advertisement -

New Targets in Developing Dementia Treatments

Beyond Amyloid and Tau

Translate to Spanish or other 102 languages!

Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research.  Image for illustration purposes
Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Image for illustration purposes

Medical News Today

- Advertisement -

Alzheimer’s disease is the most common form of dementia. Although its exact cause is unknown, for many years scientists have believed that a protein called beta-amyloid was responsible. Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Here, we round up the latest findings, look at possible advances in diagnosis, and ask: Where next for Alzheimer’s research and treatment?

To read the full story, follow the link below to Medical News Today:

https://www.medicalnewstoday.com/articles/beyond-amyloid-and-tau-new-targets-in-developing-dementia-treatments

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 

Blood Analysis Shows Whether Brain Cancer Treatment is Working

Mega Doctor News By University of Michigan Newswise — The effectiveness of chemotherapy for brain...

The Microbial Pathway That Shuts Down Diabetes Inflammation

Globally, diabetes affects roughly 529 million individuals. In the United States, estimates suggest that more than 30 million people are living with type 2 diabetes.
- Advertisement -
×